Theravance Reviews

5 Reviews
5 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
Theravance President, CEO, and Director Rick E. Winningham
Rick E. Winningham
3 Ratings

Theravance Interviews

Interview Experience

Interview Experience


Getting an Interview

Getting an Interview


Interview Difficulty


Interview Difficulty




    Senior Scientist Interview

    Anonymous Employee
    Anonymous Employee
    Interview Details

    Everyone there was really friendly and nice. Did a series of one-on-one or two-on-one interviews. Some of the interviewers seemed nervous or uncomfortable to be interviewing me. It's a small mellow company. I actually had not heard of them before coming across their job posting on this website. However, the people there don't seem like go-getters, which is or is not a good thing for some people. If you're seeking for development or more ambitious not sure if this is the company for you. They seem to just want nice people and I'm not sure if they have their eyes set on people who can actually do the job well.

    Interview Questions
    • Actually got no unexpected or difficult questions, which kind of turned me off as it seemed like the company was not serious in choosing a good candidate who can take on a challenge. Which makes me think of the quality of the people working there........   Answer Question
    No Offer

Theravance Awards and Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Headquarters South San Francisco, CA
Size 150 to 499 Employees
Founded 1996
Type Company - Public (THRX)
Industry Biotech & Pharmaceuticals
Revenue $5 to $10 million (CAD) per year

Theravance figures there's no sense in re-inventing the wheel. The biotechnology firm takes aim at already proven biological targets, taking advantage of previous years of research to create more effective, next-generation treatments. Its development programs focus on respiratory disease, bacterial infections, and gastrointestinal and neurological conditions. Its sole marketed product, VIBATIV (an injectable antibiotic approved to treat skin infections and hospital-acquired pneumonia) was successfully developed and commercialized with partner Astellas. In an exclusive... More

Work at Theravance? Share Your Experiences


Click to Rate